Standard Operating Procedure for Launch Support After Regulatory Approval
| Department | Regulatory Affairs |
| SOP No. | RA/2026/656 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 10/04/2026 |
| Effective Date | 10/04/2026 |
| Review Date | 10/04/2028 |
Purpose
This SOP establishes a standardized and controlled approach for activities related to launch support after regulatory approval. It defines essential procedures to ensure effective coordination, compliance, documentation, and communication to facilitate a smooth market entry of the product. The objective is to maintain regulatory compliance and quality standards during the launch phase, enabling timely availability while minimizing risks and deviations.
Scope
This SOP applies to all activities involved in launch support subsequent to regulatory approval within the Regulatory Affairs department and cross-functional teams including Manufacturing, Quality Assurance, Quality Control, Supply Chain, and Commercial operations. It covers document submission tracking, coordination of release and distribution, compliance verifications, training support, and communication management. This SOP is applicable to all pharmaceutical dosage forms and products registered under relevant regulatory authorities. Activities preceding regulatory approval or post-launch marketing activities beyond initial support are excluded.
Responsibilities
Regulatory Affairs personnel are responsible for coordinating and facilitating launch-related submissions, monitoring regulatory commitments, and communicating with stakeholders.
Quality Assurance supports compliance verification and training coordination.
Manufacturing and Supply Chain ensure readiness for product release and distribution.
Quality Control ensures availability of required testing data.
Commercial teams liaise for launch planning and market readiness.
All involved functions document their activities and communicate deviations or issues promptly.
Accountability
The Head of Regulatory Affairs holds overall accountability for the implementation, ongoing compliance, review, and effectiveness monitoring of this SOP. This role is also responsible for escalation of issues, coordination among functions, and ensuring timely update and training on the SOP.
Procedure
1. Preparation and Prerequisites:
- Confirm receipt of official regulatory approval documentation and update internal records.
- Verify that all regulatory commitments (post-approval obligations) are documented and communicated to relevant functions.
- Ensure that product labeling, packaging artwork, and batch release documentation comply with approved regulatory specifications.
2. Coordination for Product Launch:
- Schedule coordination meetings with cross-functional teams including Manufacturing, QA, QC, Supply Chain, and Commercial to align launch timelines and responsibilities.
- Facilitate training sessions or dissemination of regulatory requirements pertinent to the launch to all relevant stakeholders.
- Monitor availability of quality control test results, stability data, and manufacturing batch records essential for batch release.
- Confirm availability and compliance of logistics, warehousing, and distribution channels per GMP and regulatory requirements.
3. Execution and In-Process Controls:
- Monitor the batch release process ensuring compliance with all regulatory and internal quality requirements.
- Document any deviations encountered during the launch support activities and initiate corrective and preventive actions promptly.
- Track product shipment and distribution ensuring all regulatory documentation accompanies the product as required.
- Maintain communication with regulatory authorities as necessary for any immediate post-launch queries or notifications.
4. Verification and Documentation:
- Ensure all launch activities are fully documented including training records, batch release certificates, shipment records, and regulatory correspondence.
- Conduct a post-launch review to evaluate compliance, identify gaps, and implement improvements in future launches.
- File and archive all relevant documentation according to GMP documentation standards and organizational quality policy.
5. Closure:
- Prepare and submit internal launch completion reports summarizing activities, challenges, and resolutions.
- Update SOPs or work instructions if necessary based on lessons learned.
- Schedule periodic review of the SOP to maintain relevance and compliance.
Abbreviations
GMP – Good Manufacturing Practices
QA – Quality Assurance
QC – Quality Control
SOP – Standard Operating Procedure
RA – Regulatory Affairs
CAPA – Corrective and Preventive Action
Documents
Documents required for effective launch support after regulatory approval include:
- Regulatory Approval Documentation and Commitments Log (Annexure-1)
- Launch Coordination Meeting Minutes Template (Annexure-2)
- Launch Training and Compliance Checklist (Annexure-3)
References
International Conference on Harmonisation (ICH) Guidelines
World Health Organization (WHO) GMP Guidelines
21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
Internal Quality Management System Documentation
Pharmaceutical Regulatory Authority Product Launch Requirements
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Approval Documentation and Commitments Log
Purpose: To maintain a comprehensive log of regulatory approvals received and any associated post-approval commitments or obligations for product launch tracking and compliance.
| Product Name | Regulatory Authority | Approval Number | Approval Date | Commitment Description | Due Date | Status |
|---|---|---|---|---|---|---|
| Example Product A | FDA | XYZ123456 | 05/03/2026 | Submit stability data update | 05/09/2026 | Pending |
| Example Product B | EMEA | EME987654 | 12/02/2026 | Periodic safety update report | 12/08/2026 | In Progress |
Annexure-2: Launch Coordination Meeting Minutes Template
Purpose: Standardized template to document discussions, action items, and responsibilities in launch coordination meetings.
| Date: | 15/03/2026 |
| Location: | Conference Room 3B |
| Attendees: | Regulatory Affairs, QA, QC, Manufacturing, Supply Chain, Commercial |
| Agenda: Coordination of launch activities and timelines | |
| Topic | Discussion Summary | Action Items | Responsible Person | Due Date |
|---|---|---|---|---|
| Labeling Approval | Confirmed finalized approved artwork and labeling compliance | Submit finalized labels to manufacturing | Regulatory Affairs | 20/03/2026 |
| Batch Release Readiness | QC confirmed all testing completed for launch batch | Release batch following QA approval | Quality Control | 22/03/2026 |
| Training | Training materials prepared, scheduled session for Commercial team | Conduct training on regulatory updates | Quality Assurance | 21/03/2026 |
Annexure-3: Launch Training and Compliance Checklist
Purpose: Checklist to verify and document that training and compliance requirements are completed prior to product launch.
| Training Topic | Trained Staff | Date Completed | Trainer | Remarks |
|---|---|---|---|---|
| Regulatory Requirements Update | Commercial Team | 21/03/2026 | QA Trainer | Completed |
| GMP Compliance for Launch | Manufacturing & QC | 20/03/2026 | QA Trainer | Completed |
| Documentation Procedures | Supply Chain | 19/03/2026 | Regulatory Affairs | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 10/04/2026 | 1.0 | Initial issue | New SOP creation |